Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament.
Obesity is a risk factor for ossification of the posterior longitudinal ligament (OPLL) of the spine, which is characterized by heterotopic bone formation in the posterior longitudinal spinal ligament. Hyperleptinemia is a common feature of obese people and leptin is believed to be an important factor in the pathogenesis of OPLL. However, the association between leptin and bone metabolism and the development of OPLL is not understood fully. The objective of the present study was to determine the association between serum leptin concentration and bone metabolic markers and the extent of heterotopic ossification of the spinal ligament in patients with OPLL. The serum concentrations of leptin, insulin, fructosamine, bone-specific alkaline phosphatase, and carboxyterminal propeptide of type I procollagen, urine deoxypyridinoline levels, and the number of vertebrae with OPLL involvement were measured in 125 (68 males and 57 females) patients with OPLL. The correlation between leptin and these other factors was then examined. Serum leptin and insulin concentrations were increased significantly in OPLL females compared to non-OPLL female controls. In the females with OPLL, serum leptin concentrations corrected for body mass index correlated positively with the number of vertebrae with OPLL involvement. In females, serum leptin levels were significantly higher in patients in whom OPLL extended to the thoracic and/or lumbar spine than in patients in whom OPLL was limited to the cervical spine. Our results suggest that hyperleptinemia, in combination with hyperinsulinemia, may contribute to the development of heterotopic ossification of the spinal ligament in female patients with OPLL.
Department of Orthopaedic Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
Yoshikazu
Y
Ikeda
Arata
A
Nakajima
Atsuomi
A
Aiba
Masao
M
Koda
Akihiko
A
Okawa
Kazuhisa
K
Takahashi
Masashi
M
Yamazaki
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000596:Amino Acids / Q000652:urine; D015415:Biomarkers / Q000097:blood; D005260:Female; D019270:Fructosamine / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood*; D017846:Longitudinal Ligaments / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D017887:Ossification of Posterior Longitudinal Ligament / Q000097:blood* / Q000473:pathology; D009999:Ossification, Heterotopic / Q000097:blood* / Q000473:pathology; D010446:Peptide Fragments / Q000097:blood; D011347:Procollagen / Q000097:blood; D013131:Spine / Q000378:metabolism / Q000473:pathology*
D000596:Amino Acids; D015415:Biomarkers; D007328:Insulin; D020738:Leptin; D010446:Peptide Fragments; D011347:Procollagen; C042813:procollagen type I carboxy terminal peptide; D019270:Fructosamine; C036020:deoxypyridinoline; D000469:Alkaline Phosphatase
J Clin Endocrinol Metab. 1997 Apr;82(4):1293-300
9100610
Endocrinology. 2001 Aug;142(8):3546-53
11459801
Arch Oral Biol. 2008 Jun;53(6):553-7
18261710
Diabetes. 1997 Jun;46(6):1077-80
9166683
Calcif Tissue Int. 1998 Feb;62(2):158-65
9437050
Nihon Seikeigeka Gakkai Zasshi. 1994 Sep;68(9):725-36
7963927
Nat Genet. 1996 May;13(1):18-9
8673096
Biochem J. 2005 Jun 15;388(Pt 3):929-39
15715521
Spine (Phila Pa 1976). 2005 Apr 15;30(8):877-80; discussion 881
15834329
Nature. 1994 Dec 1;372(6505):425-32
7984236
Biochem Biophys Res Commun. 1996 Jul 16;224(2):597-604
8702432
Endocr J. 1996 Oct;43 Suppl:S33-41
9076340
J Orthop Res. 1997 Nov;15(6):820-9
9497806
Endocr J. 1997 Oct;44(5):671-6
9466322
Biochem Biophys Res Commun. 2000 Jan 27;267(3):752-5
10673363
Clin Orthop Relat Res. 1984 Apr;(184):71-84
6423334
Spine (Phila Pa 1976). 2008 Oct 15;33(22):2394-402
18923314
Diabetologia. 2000 Jan;43(1):3-12
10663211
Biochem Biophys Res Commun. 1996 Aug 5;225(1):75-83
8769097
J Endocrinol. 2002 Nov;175(2):405-15
12429038
Endocrinology. 1972 May;90(5):1320-30
5012744
Int J Periodontics Restorative Dent. 2009 Oct;29(5):507-13
19888494
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3258-63
14978271
Nat Med. 1995 Nov;1(11):1155-61
7584987
J Dent Res. 2008 Feb;87(2):142-7
18218840
Endocrinology. 1999 Apr;140(4):1630-8
10098497
J Biol Chem. 2007 Oct 12;282(41):29958-66
17702747
Cell Biol Int. 2004;28(3):159-69
14984741
Cell. 2000 Jan 21;100(2):197-207
10660043
Regul Pept. 2000 Aug 25;92(1-3):73-8
11024568
J Clin Endocrinol Metab. 1996 Sep;81(9):3424-7
8784109
J Spinal Disord. 1999 Jun;12(3):271-3
10382784
Front Neuroendocrinol. 2003 Jan;24(1):1-10
12609497
Calcif Tissue Int. 2006 Dec;79(6):422-30
17160579
Nihon Seikeigeka Gakkai Zasshi. 1995 Jul;69(7):440-9
7561346
FEBS Lett. 2002 Sep 25;528(1-3):40-2
12297276